Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal gastrointestinal cancers, with a rising global incidence; indeed, the worldwide burden of ...

SAN DIEGO — Experimental therapies with radically different approaches are stirring a wave of optimism that survival rates ...

In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire ...

Ben Sasse (R–Neb.), who previously served as president of the University of Florida, revealed in late December that he had ...

Results from two early-stage trials offer new hope for a cancer that kills around one in eight patients within five years.

GI Oncologist Dr. Deva Mahalingam is the lead author for research published on Tuesday. He reports that the drug Elraglusib ...

RenovoRx, Inc., which is developing targeted oncology therapies and commercializing its FDA-cleared RenovoCath drug-delivery devi ...

Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously ...

A Your question assumes that you have a parasitic infection in your pancreas. Without additional details, such as symptoms you are having, any tests you’ve done or a specific diagnosis you received, ...

India’s Sheetal Devi on Monday achieved a major milestone as she was named ‘Para Archer of the Year 2025’ by World Archery. The 19-year-old from Jammu & Kashmir became the first and only female ...

A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ever before. Researchers identified two previously unknown proteins in the ...

Pancreatic cancer continues to be a devastating disease, with an overall 5-year survival rate of around 13%. Accounting for about 3% of all cancers, it is the third leading cause of cancer death in ...